EDP Sciences logo
Search
Menu
All issues Volume 32 / No 5 (September-October 2001) Vet. Res., 32 5 (2001) 397-407 References
Free Access
Issue
Vet. Res.
Volume 32, Number 5, September-October 2001
Page(s) 397 - 407
DOI https://doi.org/10.1051/vetres:2001132
How to cite this article Vet. Res. (2001) 397-407
  1. Armstrong P.J., Derksen F.J., Slocombe R.F., Robinson N.E., Airway responses to aerosolized methacholine and citric acid in ponies with recurrent airway obstruction (heaves), Am. Rev. Respir. Dis. 133 (1986) 357-361 [PubMed].
  2. Art T., Duvivier D.H., Votion D., Anciaux N., Vandenput S., Bayly W.M., Lekeux P., Does an acute COPD crisis modify the cardiorespiratory and ventilatory adjustments to exercise in horses? J. Appl. Physiol. 84 (1998) 845-852 [PubMed].
  3. Banerjee M., Kang K.H., Morrow J.D., Roberts L.J., Newman J.H., Effects of a novel prostaglandin, 8-epi-PGF $_{2\alpha}$, in rabbit lung in situ, Am. J. Physiol. 263 (1992) H660-H663 [PubMed].
  4. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M., Asthma: From bronchoconstriction to airways inflammation and remodeling, Am. J. Respir. Crit. Care. Med. 161 (2000) 1720-1745 [PubMed].
  5. Broadstone R.F., Scott J.S., Derksen F.J., Robinson N.E., Effects of atropine in ponies with recurrent airway obstruction, J. Appl. Physiol. 65 (1988) 2720-2725 [PubMed].
  6. Brusasco V., Crimi E., Pellegrino R., Airway hyperresponsiveness in asthma: not just a matter of airway inflammation, Thorax 53 (1998) 992-998 [PubMed].
  7. Bureau F., Delhalle S., Bonizzi G., Fiévez L., Dogné S., Kirschvink N., Vanderplasschen A., Merville M.-P., Bours V., Lekeux P., Mechanisms of persistent NF-$\kappa$B activity in the bronchi of an animal model of asthma, J. Immunol. 165 (2000) 5822-5830 [PubMed].
  8. Derksen F.J., Robinson N.E., Armstrong P.J., Stick J.A., Slocombe R.F., Airway reactivity in ponies with recurrent airway obstruction (heaves), J. Appl. Physiol. 58 (1985) 598-604 [PubMed].
  9. Doucet M.Y., Jones T.R., Ford-Hutchinson A.W., Responses of equine trachealis and lung parenchyma to methacholine, histamine, serotonin, prostanoids and leukotrienes in vitro, Can. J. Physiol. Pharmacol. 68 (1990) 379-383 [PubMed].
  10. Elias J.A., Zhu Z., Chupp G., Homer R.J., Airway remodeling in asthma, J. Clin. Invest. 104 (1999) 1001-1006 [PubMed].
  11. Fukunaga M., Makita N., Roberts L.J. II, Morrow J.D., Takahashi K., Badr K.F., Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells, Am. J. Physiol. 264 (1993) C1619-C1624 [PubMed].
  12. Gray P.R., Derksen F.J., Robinson N.E., Carpenter-Deyo L.J., Johnson H.G., Roth R.A., The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves, Am. Rev. Respir. Dis. 140 (1989) 154-160 [PubMed].
  13. Hansen G., Berry G., DeKruyff R.H., Umetsu D.T., Allergen specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation, J. Clin. Invest. 103 (1999) 175-183 [PubMed].
  14. Hulsmann A.R., Raatgeep H.R., den Hollander J.C., Stijnen T., Saxena P.R., Kerrebijn K.F., De Jongste J.C., Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways, Am. J. Respir. Crit. Care Med. 149 (1994) 519-525 [PubMed].
  15. Jatakanon A., Uasuf C., Maziak W., Lim S., Chung K.F., Barnes P.J., Neutrophilic inflammation in severe persistent asthma, Am. J. Respir. Crit. Care Med. 160 (1999) 1532-1539 [PubMed].
  16. Kaup F.-J., Drommer W., Damsch S., Deegen E., Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD) II: pathomorphological changes of the terminal airways and the alveolar region, Equine Vet. J. 22 (1990) 349-355 [PubMed].
  17. Kawikova I.P., Barnes J., Takahashi T., Tadjkarimi S., Yacoub M.H., Belvisi M.G., 8-Epi-PGF $_{2\alpha}$, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro, Am. J. Respir. Crit. Care Med. 153 (1996) 590-596 [PubMed].
  18. Kirschvink N., Art T., Smith N., Lekeux P., Effect of exercise and COPD crisis on isoprostane concentration in plasma and bronchoalveolar lavage fluid in horses, Equine Vet. J. Suppl 30 (1999) 88-91 [PubMed].
  19. Lawson J.A., Rokach J., FitzGerald G.A., Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo, J. Biol. Chem. 274 (1999) 24441-24444 [CrossRef] [PubMed].
  20. Montuschi P., Ciabattoni G., Paredi P., Pantelidis P., du Bois R.M., Kharitonov S.A., Barnes P.J., 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases, Am. J. Respir. Crit. Care Med. 158 (1998) 1524-1527 [PubMed].
  21. Montuschi P., Corradi M., Ciabattoni G., Nightingale J., Kharitonov S.A., Barnes P.J., Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients, Am. J. Respir. Crit. Care Med. 160 (1999) 216-220 [PubMed].
  22. Montuschi P., Collins J.V., Ciabattoni G., Lazzeri N., Corradi M., Kharitonov S.A., Barnes P.J., Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers, Am. J. Respir. Crit. Care Med. 162 (2000) 1175-1177 [PubMed].
  23. Morrow J.D., Roberts L.J. II, The isoprostanes. Current knowledge and directions for future research, Biochem. Pharmacol. 51 (1996) 1-9 [CrossRef] [PubMed].
  24. Nadel J.A., Busse W.W., Asthma, Am. J. Respir. Crit. Care Med. 157 (1998) S130-S138 [PubMed].
  25. Okazawa A., Kawikova I., Cui Z.H., Skoogh B.E., Lötvall J., 8-Epi-PGF2a induces airflow obstruction and airway plasma exudation in vivo, Am. J. Respir. Crit. Care Med. 155 (1997) 436-441 [PubMed].
  26. Postma D.S., Kerstjens H.A., Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med. 158 (1998) S187-S192 [PubMed].
  27. Reilly M., Delanty N., Lawson J.A., FitzGerald G.A., Modulation of oxidant stress in vivo in chronic cigarette smokers, Circulation 94 (1996) 19-25 [PubMed].
  28. Robinson N.E., Derksen F.J., Olszewski M.A., Buechner-Maxwell V.A., The pathogenesis of chronic obstructive pulmonary disease of horses, Br. Vet. J. 152 (1996) 283-305 [PubMed].
  29. Vandenput S., Votion D., Duvivier D.H., van Erck E., Anciaux N., Art T., Lekeux P., Effect of a set stabled environmental control on pulmonary function and airway reactivity of COPD affected horses, Vet. J. 155 (1998) 189-195 [CrossRef] [PubMed].
  30. Votion D., Ghafir Y., Munsters K., Duvivier D.H., Art T., Lekeux P., Aerosol deposition in equine lungs following ultrasonic nebulisation versus jet aerosol delivery system, Equine Vet. J. 29 (1997) 388-393 [PubMed].
  31. Watson E.D., Sweeney C.R., Steensma K.A., Arachidonate metabolites in bronchoalveolar lavage fluid from horses with and without COPD, Equine Vet. J. 24 (1992) 379-381 [PubMed].